Qiyi Meng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Genetic profiling of circulating cell-free DNA from cerebrospinal fluid and paired plasma in ALK-positive lung cancer with brain metastases.
Journal: Thoracic cancer
Published: April 06, 2023
Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports.
Journal: Frontiers in oncology
Published: December 10, 2022
Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer.
Journal: Frontiers in oncology
Published: May 30, 2022
ALK-rearranged squamous cell carcinoma of the lung.
Journal: Thoracic cancer
Published: October 30, 2020
Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases.
Journal: Frontiers in oncology
Published: October 27, 2020
Adverse events of afatinib as first-line treatment for five cases of advanced lung adenocarcinoma and review of literature
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 25, 2014
Long-term survival of a patient with advanced non-small cell lung cancer on bevacizumab therapy: case report and review of the literature
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 18, 2013
Vandetanib treatment in refractory advanced lung adenocarcinoma patients: five cases and review of literature
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026